Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Carlsen, N T"'
Autor:
Birgitte Klug Albertsen, Schrøder, H., Jakobsen, P., Müller, H. J., Carlsen, N. T., Schmiegelow, K.
Publikováno v:
Albertsen, B K, Schrøder, H, Jakobsen, P, Müller, H-J, Carlsen, N T & Schmiegelow, K 2001, ' Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries ', Br. J. Clin. Pharmacol., vol. 52(4), pp. 433-437 .
Albertsen, BK, Schrøder, H, Jakobsen, P, Müller, H J, Carlsen, N T & Schmiegelow, K 2001, ' Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries ', British Journal of Clinical Pharmacology. Supplement, vol. 52, no. 4, pp. 433-7 .
Aarhus University
Albertsen, B K, Schrøder, H, Jakobsen, P, Müller, H J, Carlsen, N T & Schmiegelow, K 2001, ' Monitoring of Erwinia asparaginase therapy in childhood ALL in the nordic countries ' Br. J. Clin. Pharmacol., vol. 52, pp. 433-437 .
Albertsen, BK, Schrøder, H, Jakobsen, P, Müller, H J, Carlsen, N T & Schmiegelow, K 2001, ' Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries ', British Journal of Clinical Pharmacology. Supplement, vol. 52, no. 4, pp. 433-7 .
Aarhus University
Albertsen, B K, Schrøder, H, Jakobsen, P, Müller, H J, Carlsen, N T & Schmiegelow, K 2001, ' Monitoring of Erwinia asparaginase therapy in childhood ALL in the nordic countries ' Br. J. Clin. Pharmacol., vol. 52, pp. 433-437 .
AIMS: Evaluation of L-asparaginase therapy in the NOPHO-92 ALL-protocol (treatment protocol of acute lymphoblastic leukaemia of the Nordic Society of Paediatric Haematology and Oncology, initiated in 1992) after intravenous and intramuscular administ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::73d97b8da98563ad4dcefee7d820524b
https://europepmc.org/articles/PMC2014586/
https://europepmc.org/articles/PMC2014586/
Autor:
Albertsen, BK, Schrøder, H, Ingerslev, J, Jakobsen, P, Avramis, V I, Müller, H J, Carlsen, N T, Schmiegelow, K
Publikováno v:
Albertsen, B K, Schrøder, H, Ingerslev, J, Jakobsen, P, Avramis, V I, Müller, H J, Carlsen, N T & Schmiegelow, K 2001, ' Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac : Pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system ' British J of Haematology, vol. 115, pp. 983-990 .
Albertsen, BK, Schrøder, H, Ingerslev, J, Jakobsen, P, Avramis, V I, Müller, H J, Carlsen, N T & Schmiegelow, K 2001, ' Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac : pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system ', British Journal of Haematology, vol. 115, no. 4, pp. 983-90 .
Albertsen, BK, Schrøder, H, Ingerslev, J, Jakobsen, P, Avramis, V I, Müller, H J, Carlsen, N T & Schmiegelow, K 2001, ' Comparison of intramuscular therapy with Erwinia asparaginase and asparaginase Medac : pharmacokinetics, pharmacodynamics, formation of antibodies and influence on the coagulation system ', British Journal of Haematology, vol. 115, no. 4, pp. 983-90 .
Asparaginase comes from different biological sources and the various preparations have different pharmacokinetic properties, and their tendency to induce side-effects is different. Erwinia asparaginase (ASNase) has a shorter half-life than the Escher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::103b254168c1377bd2258fb8d2036903
https://pure.au.dk/portal/da/publications/comparison-of-intramuscular-therapy-with-erwinia-asparaginase-and-asparaginase-medac(eeb39860-b2d0-11da-bee9-02004c4f4f50).html
https://pure.au.dk/portal/da/publications/comparison-of-intramuscular-therapy-with-erwinia-asparaginase-and-asparaginase-medac(eeb39860-b2d0-11da-bee9-02004c4f4f50).html
Autor:
Albertsen, Birgitte, Jakobsen, Preben, Schrøder, Henrik, Schmiegelow, Kjeld, Carlsen, Niels T., Albertsen, B K, Jakobsen, P, Schrøder, H, Schmiegelow, K, Carlsen, N T
Publikováno v:
Cancer Chemotherapy & Pharmacology; Jul2001, Vol. 48 Issue 1, p77-82, 6p
Autor:
Albertsen BK; Centre for Clinical Pharmacology, Department of Pharmacology, The Bartholin Building, University of Aarhus, 8000 Aarhus C, Denmark. bka@farm.au.dk, Schrøder H, Ingerslev J, Jakobsen P, Avramis VI, Müller HJ, Carlsen NT, Schmiegelow K
Publikováno v:
British journal of haematology [Br J Haematol] 2001 Dec; Vol. 115 (4), pp. 983-90.
Autor:
Schrøder H; Department of Pediatrics, University Hospital of Aarhus., Agger KE, Rosthøj S, Carlsen NT, Schmiegelow K
Publikováno v:
Danish medical bulletin [Dan Med Bull] 2001 Nov; Vol. 48 (4), pp. 275-7.
Autor:
Albertsen BK; Centre for Clinical Pharmacology, University of Aarhus, Aarhus, Denmark. bka@farm.au.dk, Schrøder H, Jakobsen P, Müller HJ, Carlsen NT, Schmiegelow K
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2001 Oct; Vol. 52 (4), pp. 433-7.
Autor:
Heegaard ED; Klinisk mikrobiologisk afdeling, H:S Rigshospitalet, København., Kerndrup GB, Carlsen NT, Schmiegelow K, Hornsleth AK
Publikováno v:
Ugeskrift for laeger [Ugeskr Laeger] 1999 Nov 22; Vol. 161 (47), pp. 6501-2.